Feedback / Questions
Reyvow (lasmiditan) - Eli Lilly, Daiichi Sankyo, Organon
Reyvow: Protection of compound patent in US/Japan until 2028
(Eli Lilly)
-
Mar 6, 2025 -
Annual Report 2024: Regulatory data protection in EU/Japan until 2032
Commercial • Patent
•
CNS Disorders • Migraine • Pain
https://investor.lilly.com/static-files/5c870f9a-45f1-4da1-b2cc-4fd18ff6e82b
Mar 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious